Form 4: UNITED THERAPEUTICS CEO Sells Shares
Insider Transaction (Form 4)
Martine A Rothblatt, Chairperson & CEO and a Director of UNITED THERAPEUTICS Corp, sold 9,500 shares of common stock on July 16, 2026.
Summary
- Option exercise/conversion: acquired 9,500 Common Stock at $135.42 ($1,286,490) on July 16, 2026; holds 333,943 after (Indirect).
- Open-market sale: disposed of 80 Common Stock at $527.31 ($42,185) on July 16, 2026; holds 333,863 after (Indirect).
- Open-market sale: disposed of 1,400 Common Stock at $528.42 ($739,783) on July 16, 2026; holds 332,463 after (Indirect).
- Open-market sale: disposed of 3,057 Common Stock at $529.46 ($1,618,572) on July 16, 2026; holds 329,406 after (Indirect).
- Open-market sale: disposed of 1,924 Common Stock at $530.14 ($1,019,999) on July 16, 2026; holds 327,482 after (Indirect).
- Open-market sale: disposed of 520 Common Stock at $532.14 ($276,712) on July 16, 2026; holds 326,962 after (Indirect).
- Open-market sale: disposed of 440 Common Stock at $533.28 ($234,644) on July 16, 2026; holds 326,522 after (Indirect).
- Open-market sale: disposed of 1,198 Common Stock at $534.31 ($640,101) on July 16, 2026; holds 325,324 after (Indirect).
- Open-market sale: disposed of 720 Common Stock at $535.20 ($385,342) on July 16, 2026; holds 324,604 after (Indirect).
- Open-market sale: disposed of 150 Common Stock at $536.29 ($80,443) on July 16, 2026; holds 324,454 after (Indirect).
- Open-market sale: disposed of 11 Common Stock at $537.11 ($5,908) on July 16, 2026; holds 324,443 after (Indirect).
- Option exercise/conversion: disposed of 9,500 Stock Option on July 16, 2026; holds 331,910 after (Indirect).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $5,043,689 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Martine A Rothblatt — Director, Officer (Chairperson & CEO)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-16 | Option exercise/conversion | Common Stock | 9,500 | $135 | $1.3M | 333,943 |
| 2026-07-16 | Open-market sale | Common Stock | 80 | $527 | $42.2K | 333,863 |
| 2026-07-16 | Open-market sale | Common Stock | 1,400 | $528 | $739.8K | 332,463 |
| 2026-07-16 | Open-market sale | Common Stock | 3,057 | $529 | $1.6M | 329,406 |
| 2026-07-16 | Open-market sale | Common Stock | 1,924 | $530 | $1.0M | 327,482 |
| 2026-07-16 | Open-market sale | Common Stock | 520 | $532 | $276.7K | 326,962 |
| 2026-07-16 | Open-market sale | Common Stock | 440 | $533 | $234.6K | 326,522 |
| 2026-07-16 | Open-market sale | Common Stock | 1,198 | $534 | $640.1K | 325,324 |
| 2026-07-16 | Open-market sale | Common Stock | 720 | $535 | $385.3K | 324,604 |
| 2026-07-16 | Open-market sale | Common Stock | 150 | $536 | $80.4K | 324,454 |
| 2026-07-16 | Open-market sale | Common Stock | 11 | $537 | $5.9K | 324,443 |
| 2026-07-16 | Option exercise/conversion | Stock Option | 9,500 | — | — | 331,910 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-16 | Option exercise/conversion (9,500 shares) |
| 2026-07-16 | Open-market sale (80 shares) |
| 2026-07-16 | Open-market sale (1,400 shares) |
| 2026-07-16 | Open-market sale (3,057 shares) |
| 2026-07-16 | Open-market sale (1,924 shares) |
| 2026-07-16 | Open-market sale (520 shares) |
| 2026-07-16 | Open-market sale (440 shares) |
| 2026-07-16 | Open-market sale (1,198 shares) |
| 2026-07-16 | Open-market sale (720 shares) |
| 2026-07-16 | Open-market sale (150 shares) |
| 2026-07-16 | Open-market sale (11 shares) |
| 2026-07-16 | Option exercise/conversion (9,500 shares) |
Keywords
insider transaction, Form 4, UTHR, UNITED THERAPEUTICS Corp, bearish, Martine A Rothblatt
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.